Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
Clinical trial NCT03831633 · UNKNOWN
Trial details
- NCT number
- NCT03831633
- Sponsor
- VIFORFRANCE
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2019-07-31
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.